Compare BioNTech SE - ADR (BNTX) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs McKesson Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while McKesson Corporation trades at $894.99 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 4.5× BioNTech SE - ADR's market cap, and McKesson Corporation pays a 0.42% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | MCK | |
|---|---|---|
Market Cap | $23.31B | $105.14B |
Sector | Health | Health |
52-Week High | $119.34 | $995.69 |
52-Week Low | $83.89 | $659.01 |
Enterprise Value | $6.60B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
